Pfizer has won early antitrust approval for its acquisition of obesity biotech Metsera, beating back a $9 billion unsolicited bid from Novo Nordisk. The FTC’s move during a government shutdown signals regulatory priorities in the heated weight-loss drug competition.
FTC Removes Key AI Guidance Documents The Federal Trade Commission has quietly removed three significant blog posts from the Lina…
The Disappearing AI Guidance In a quiet but significant digital transformation, the Federal Trade Commission has been systematically removing AI…
The Disappearing Act: FTC Removes Key AI Policy Content In a move that has raised eyebrows across the technology and…
